Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samy Hadjadj

Showing results (51-60 of 216) with videos related to

Pageof 22
Sort By:
Diabetes, Obesity & Metabolism|January 20, 2026
Methylglyoxal-glycated apolipoproteins A-I and A-II are associated with new-onset diabetes in individuals with prediabetesChloé Chevalier, Arsênio Rodrigues Oliveira, Matthieu Wargny, et al.
Diabetes, Obesity & Metabolism|May 3, 2024
Empagliflozin mitigates metabolic dysfunction-associated steatotic liver disease by reducing de novo lipogenesis in a mouse model of lipoatrophic diabetesSarra Smati, Thibaud Sotin, Perrine Deniel, et al.
Kidney International|February 4, 2023
Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with semaglutide experience more stable kidney function compared with placeboKatherine R Tuttle, Heidrun Bosch-Traberg, David Z I Cherney, et al.
The Journal of Clinical Endocrinology and Metabolism|February 4, 2025
Body-weight Cycling and Risk of Diabetic Kidney Disease in People With Type 1 Diabetes in the DCCT/EDIC PopulationMarion Camoin, Kamel Mohammedi, Pierre-Jean Saulnier, et al.
Diabetes Care|May 18, 2022
Plasma Adrenomedullin, Allelic Variations in the ADM Gene, and Risk for Lower-Limb Amputation in People With Type 2 DiabetesLouis Potier, Kamel Mohammedi, Pierre-Jean Saulnier, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 13, 2017
T-cadherin gene variants are associated with nephropathy in subjects with type 1 diabetesAnthony Nicolas, Kamel Mohammedi, Jean-Philippe Bastard, et al.
Environmental Science & Technology|July 17, 2019
Bisphenol A, Chlorinated Derivatives of Bisphenol A and Occurrence of Myocardial Infarction in Patients with Type 2 Diabetes: Nested Case-Control Studies in Two European CohortsChunyun Hu, Ben Schöttker, Nicolas Venisse, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 20, 2017
T-cadherin gene variants are associated with nephropathy in subjects with type 1 diabetesAnthony Nicolas, Kamel Mohammedi, Jean-Philippe Bastard, et al.
Diabetes Care|December 22, 2019
Association of Urine Haptoglobin With Risk of All-Cause and Cause-Specific Mortality in Individuals With Type 2 Diabetes: A Transethnic Collaborative WorkJian-Jun Liu, Sylvia Liu, Pierre-Jean Saulnier, et al.
Diabetes Care|December 22, 2016
Association of Circulating Biomarkers (Adrenomedullin, TNFR1, and NT-proBNP) With Renal Function Decline in Patients With Type 2 Diabetes: A French Prospective CohortPierre-Jean Saulnier, Elise Gand, Gilberto Velho, et al.
Pageof 22

Showing results (51-60 of 216) with videos related to

Sort By:
Pageof 22
Diabetes, Obesity & Metabolism|January 20, 2026
Methylglyoxal-glycated apolipoproteins A-I and A-II are associated with new-onset diabetes in individuals with prediabetesChloé Chevalier, Arsênio Rodrigues Oliveira, Matthieu Wargny, et al.
Diabetes, Obesity & Metabolism|May 3, 2024
Empagliflozin mitigates metabolic dysfunction-associated steatotic liver disease by reducing de novo lipogenesis in a mouse model of lipoatrophic diabetesSarra Smati, Thibaud Sotin, Perrine Deniel, et al.
Kidney International|February 4, 2023
Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with semaglutide experience more stable kidney function compared with placeboKatherine R Tuttle, Heidrun Bosch-Traberg, David Z I Cherney, et al.
The Journal of Clinical Endocrinology and Metabolism|February 4, 2025
Body-weight Cycling and Risk of Diabetic Kidney Disease in People With Type 1 Diabetes in the DCCT/EDIC PopulationMarion Camoin, Kamel Mohammedi, Pierre-Jean Saulnier, et al.
Diabetes Care|May 18, 2022
Plasma Adrenomedullin, Allelic Variations in the ADM Gene, and Risk for Lower-Limb Amputation in People With Type 2 DiabetesLouis Potier, Kamel Mohammedi, Pierre-Jean Saulnier, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 13, 2017
T-cadherin gene variants are associated with nephropathy in subjects with type 1 diabetesAnthony Nicolas, Kamel Mohammedi, Jean-Philippe Bastard, et al.
Environmental Science & Technology|July 17, 2019
Bisphenol A, Chlorinated Derivatives of Bisphenol A and Occurrence of Myocardial Infarction in Patients with Type 2 Diabetes: Nested Case-Control Studies in Two European CohortsChunyun Hu, Ben Schöttker, Nicolas Venisse, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 20, 2017
T-cadherin gene variants are associated with nephropathy in subjects with type 1 diabetesAnthony Nicolas, Kamel Mohammedi, Jean-Philippe Bastard, et al.
Diabetes Care|December 22, 2019
Association of Urine Haptoglobin With Risk of All-Cause and Cause-Specific Mortality in Individuals With Type 2 Diabetes: A Transethnic Collaborative WorkJian-Jun Liu, Sylvia Liu, Pierre-Jean Saulnier, et al.
Diabetes Care|December 22, 2016
Association of Circulating Biomarkers (Adrenomedullin, TNFR1, and NT-proBNP) With Renal Function Decline in Patients With Type 2 Diabetes: A French Prospective CohortPierre-Jean Saulnier, Elise Gand, Gilberto Velho, et al.
Pageof 22